# Pfizer — NAFDAC-Registered Products & Company Profile

Pfizer holds 24 active NAFDAC product registrations in our October 2026 copy of the Greenbook.

- Source: https://ogbogwu.com/manufacturers/pfizer/
- NAFDAC-registered products: 24 · Cholesterol, Pain & Fever, Antibiotics
- Made in: Germany (10), France (3), Italy (3)
- Headquarters: New York, United States
- Website: pfizer.com (https://www.pfizer.com)
- Address & phone: Not on record here — see the official website.
- Rank by registered products: 54 of 533 manufacturers tracked (October 2026 copy)
- Country: United States
- Nigerian company: no

## Register profile (October 2026 copy)

Pfizer has 24 products registered with NAFDAC for the Nigerian market in our October 2026 copy of the Greenbook. The full list below is compiled from that copy of the NAFDAC Greenbook — Nigeria's official register of approved products.
Its registrations span drugs (23) and vaccines and biologics (1). Its medicines are strongest in Cholesterol (4 products), Pain & Fever (2 products) and Antibiotics (1 product). Its vaccines and biologics range covers meningococcal acwy conjugate vaccine (1). Registered brands include Cytotec 200 mcg Tablets, Diflucan 50 mg Capsules and Lipitor 10 mg Tablets. Most of its products are registered as capsule, tablet and powder for solution for injection/infusion formulations. 9 of its products link through to full Ogbogwu drug guides covering uses, dosage, prices, and NAFDAC verification. Pfizer is the registration holder rather than the physical maker: the Greenbook records factories abroad for its products (mostly Germany).

## Product categories (October 2026 copy)

- Cholesterol: 4 products
- Pain & Fever: 2 products
- Antibiotics: 1 product

## Registered products in our October 2026 copy

| Product | NAFDAC Reg. No. | Strength | Form |
|---|---|---|---|
| Braftovi 50 mg Capsules | A4-100330 | 50 mg | Capsule |
| Braftovi 75 mg Capsules | A4-100331 | 75 mg | Capsule |
| Cytotec 200 mcg Tablets | B4-0307 | 200 mcg | Tablet |
| Dalacin C 150 mg Capsules | 04-1261 | 150 mg | Capsule |
| Dalacin C 300 mg Capsules | B4-0845 | 300 mg | Capsule |
| Diflucan 50 mg Capsules | 04-1426 | 50 mg | Capsule |
| Eliquis 5 mg Tablets | B4-1192 | 5 mg | Tablet |
| Ibrance 100 mg Capsules | B4-9328 | 100 mg | Capsule |
| Ibrance 125 mg Capsules | B4-9327 | 125 mg | Capsule |
| Ibrance 75 mg Capsules | B4-9329 | 75 mg | Capsule |
| Lipitor 10 mg Tablets | 04-3160 | 10 mg | Tablet |
| Lipitor 20 mg Tablets | 04-3159 | 20 mg | Tablet |
| Lipitor 40 mg Tablets | 04-3158 | 40 mg | Tablet |
| Lipitor 80 mg Tablets | A4-5732 | 80 mg | Tablet |
| Lyrica 25 mg Capsules | A4-0004 | 25 mg | Capsule |
| Mektovi 15 mg Tablets | A4-100332 | 15 mg | Tablet |
| Meronem 500 mg IV Powder for Injection | A4-6947 | 500 mg | Powder for solution for injection/infusion |
| Meronem Powder for Injection 1 g IV | A4-6948 | 1 g | Powder for solution for injection/infusion |
| Nimenrix Vaccine | A6-0259 | 0.5 mL | Powder for injection |
| Paclitaxel 100 mg/16.7 mL Concentrate For Solution For Infusion | A4-100142 | 100 mg/16.67 mL | Concentrate for solution for infusion |
| Paclitaxel 300 mg/50 mL Concentrate For Solution For Infusion | A4-100143 | 300 mg/50 mL | Concentrate for solution for infusion |
| Ponstan Capsules | 04-9502 | 250 mg | Capsule |
| Xeljanz 5 mg Tablets | B4-7139 | 5 mg | Tablet |
| Zavicefta 2 g/0.5 g Powder for Concentrate for Solution for Infusion | A4-100347 | 2 g; 0.5 g | Powder for solution for injection/infusion |

Verify any NAFDAC number free: https://ogbogwu.com/nafdac-checker/